Ticagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percu...
Ticagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percutaneous Coronary Intervention
About this item
Full title
Author / Creator
Xi, Ziwei , Zhou, Yujie , Zhao, Yingxin , Liu, Xiaoli , Liang, Jing , Chai, Meng , Yu, Ying and Liu, Wei
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
Purpose
To compare the risk of cardiovascular events between patients with two CYP2C19 loss-of-function alleles who were prescribed ticagrelor or clopidogrel after percutaneous coronary intervention (PCI).
Methods
Patients with two loss-of-function alleles based on the CYP2C19 genotype were selected from patients enrolled in a retrospectiv...
Alternative Titles
Full title
Ticagrelor Versus Clopidogrel in Patients with Two CYP2C19 Loss-of-Function Alleles Undergoing Percutaneous Coronary Intervention
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2385885876
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2385885876
Other Identifiers
ISSN
0920-3206,1573-7241
E-ISSN
1573-7241
DOI
10.1007/s10557-020-06956-4